Definitive Materials Filed by Investment Companies. (497)
March 26 2014 - 4:05PM
Edgar (US Regulatory)
Stradley, Ronon, Stevens & Young,
LLP
2005 Market Street, Suite 2600
Philadelphia, Pennsylvania
19103-7018
(215) 564-8000
March 26, 2014
VIA EDGAR
TRANSMISSION
Filing Desk
U.S. Securities and
Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Attention:
James OConnor
|
RE:
|
|
Delaware Group Adviser Funds (the
Registrant)
File Nos.
811-07972; 033-67490
|
Dear Sir or Madam:
Pursuant to Rule 497(c) under the
Securities Act of 1933, as amended, submitted electronically via the EDGAR
system, please find enclosed certain risk/return summary information in an
interactive data format using the eXtensible Business Reporting Language (the
XBRL exhibits). The XBRL exhibits reflect the Item 2, 3 and 4 risk/return
summary disclosure required by Form N-1A, which disclosure was included in the
definitive prospectus dated February 28, 2014, for the Delaware Diversified
Income Fund, series of the Registrant, that was filed with the U.S. Securities
and Exchange Commission via the EDGAR system on March 5, 2014 (Accession
No.
0001206774-14-000754) pursuant to Rule 497( c) under the Securities Act
of 1933.
No XBRL exhibits are being filed by
the Registrant for the other series of the Registrant because the Item 2, 3 and
4 risk/return summary disclosure for the other series of the Registrant did not
differ from that which was included in the XBRL exhibits in Post-Effective
Amendment No. 50 filed on March 21, 2014.
If you have any questions or
comments regarding this filing, please call me at (215) 564-8099.
Very truly
yours,
|
|
/s/
Jonathan M.
Kopcsik
|
|
Jonathan M.
Kopcsik
|
cc:
|
|
Jerel A.
Hopkins
Bruce G. Leto
|
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From Apr 2023 to Apr 2024